Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03866473 · ClinicalTrials.gov registry record · NA
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema
A NA study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT03866473 is a NA study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 135 participants.
The verdict
NCT03866473, a NA study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
Randomized clinical trial evaluating the effect of photobiomodulation compared with sham on central subfield thickness (CST) in eyes with central-involved DME and good vision.
Interventions
- DEVICE Retilux
- DEVICE Sham Light Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2020-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03866473
The ClinicalTrials.gov registry entry for NCT03866473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Retilux is the first listed.
NCT03866473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03866473 about?
NCT03866473 is a clinical study titled "A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema". Randomized clinical trial evaluating the effect of photobiomodulation compared with sham on central subfield thickness (CST) in eyes with central-involved DME and good vision.
What is the current status of trial NCT03866473?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2019-04-10. Estimated completion is 2020-11-13.
What interventions are being tested in trial NCT03866473?
The interventions under investigation include: Retilux (DEVICE), Sham Light Device (DEVICE).
Who is sponsoring clinical trial NCT03866473?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.